1-10 of 10
Taizo Shimomura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study

Saki Ogawa, Kotaro Shide, Masami Takeuchi, Kosei Matsue, Takuro Kameda, Masato Yasumi, Takahiro Karasuno, Taizo Shimomura, Hitoshi Suzushima, Kiyoshi Yamashita, Noriaki Kawano, Osamu Imataki, Norimitsu Kadowaki, Akihito Yonezawa, Eiichi Otsuka, Yoshio Saburi, Yuki Tahira, Ayako Kamiunten, Keiichi Akizuki, Masayoshi Karasawa, Ryoma Ikeda, Kengo Matsumoto, Ayuka Kuroki, Koshiro Nagamine, Yoko Kubuki, Kazuya Shimoda
Journal: Blood
Blood (2024) 144 (Supplement 1): 1805.
https://doi.org/10.1182/blood-2024-208908
Published: 2024
Journal Articles

Phase 1/2 Study of the Activin Receptor-like Kinase-2 Inhibitor Zilurgisertib (INCB000928, LIMBER-104) As Monotherapy or with Ruxolitinib in Patients with Anemia Due to Myelofibrosis

Sanjay Mohan, Stephen Oh, Jean-Jacques Kiladjian, Masahiro Takeuchi, Jason Gotlib, Ellen K. Ritchie, Taizo Shimomura, Paola Guglielmelli, Anthony M. Hunter, Francesca Palandri, Francoise Boyer, Alessandro Rambaldi, Takehiko Mori, Tomoki Ito, Betty Lamothe, Yan-Ou Yang, Yi Cui, Francis Seguy, Amanda McBride, Prithviraj Bose
Journal: Blood
Blood (2023) 142 (Supplement 1): 624.
https://doi.org/10.1182/blood-2023-179291
Published: 2023
Journal Articles

Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period

Katsuto Takenaka, MD PhD, Kazuya Shimoda, MD, PhD, Naoyuki Uchida, MDPhD, Taizo Shimomura, MD PhD, Koji Nagafuji, MD PhD, Tadakazu Kondo, MD PhD, Hirohiko Shibayama, MDPhD, Takehiko Mori, MD PhD, Kensuke Usuki, MD PhD, Taichi Azuma, MDPhD, Yutaka Tsutsumi, MD PhD, Junji Tanaka, MD PhD, Hitomi Dairaku, Keitaro Matsuo, MDPhD, Keiya Ozawa, MD PhD, Mineo Kurokawa, MD, PhD, Shunya Arai, MD, PhD, Koichi Akashi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3126.
https://doi.org/10.1182/blood.V128.22.3126.3126
Published: 2016
Journal Articles

IDH1 and IDH2 Mutations Confer An Adverse Effect In Patients With Acute Myeloid Leukemia Lacking The NPM1 Mutation

Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4977.
https://doi.org/10.1182/blood.V122.21.4977.4977
Published: 2013
Journal Articles

Accumulation Of Gene Alterations Of TP53 , Crebbp and IKZF1 Is a Prognostic Factor In Adult Acute Lymphoblastic Leukemia

Kenji Tokunaga, MD, Shunichro Yamaguchi, MD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1386.
https://doi.org/10.1182/blood.V122.21.1386.1386
Published: 2013
Journal Articles

Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia

Kenji Tokunaga, MD, Shunichiro Yamaguchi, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Mitsuya Hiroaki, MD, PhD, Norio Asou, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1419.
https://doi.org/10.1182/blood.V120.21.1419.1419
Published: 2012
Journal Articles

Prognostic Impact and Concurrent Genetic Alterations of CEBPA Double Mutations in Adults with Cytogenetically Intermediate-Risk Acute Myeloid Leukemia.

Shunichiro Yamaguchi, MD, Kenji Tokunaga, MD, Eisaku Iwanaga, MD, PhD, Tomoko Nanri, MD, PhD, Taizo Shimomura, MD, PhD, Hitoshi Suzushima, MD, PhD, Hiroaki Mitsuya, Norio Asou, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2538.
https://doi.org/10.1182/blood.V120.21.2538.2538
Published: 2012
Journal Articles

IDH2 Mutations Have An Unfavorable Impact in Elderly Patients with Acute Myeloid Leukemia

Shunichro Yamaguchi, MD, Eisaku Iwanaga, MD, Kenji Tokunaga, MD, Tomoko Nanri, MD, PhD, Hitoshi Suzushima, MD, PhD, Taizo Shimomura, MD, PhD, Hiroaki Mitsuya, MD, PhD, Norio Asou, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2519.
https://doi.org/10.1182/blood.V118.21.2519.2519
Published: 2011
Journal Articles

Seven-Year Follow-up of Patients Receiving Imatinib for the Treatment of Chronic Myelogenous Leukemia by the TARGET System

Tetsuzo Tauchi, M.D., Masahiro Kizaki, M.D., Shinichiro Okamoto, M.D., Hideo Tanaka, M.D., Mitsune Tanimoto, M.D., Koiti Inokuchi, M.D., Tohru Murayama, M.D., Yoshio Saburi, M.D., Masayuki Hino, M.D., Mitsuru Tsudo, M.D., Taizo Shimomura, M.D., Yasushi Isobe, M.D., Kazuo Oshimi, MD, Kazuo Dan, M.D., Kazuma Ohyashiki, M.D., Yasuo Ikeda, M.D.
Journal: Blood
Blood (2010) 116 (21): 2287.
https://doi.org/10.1182/blood.V116.21.2287.2287
Published: 2010
Journal Articles

Activated Dendritic Cells From Bone Marrow Cells of Mice Receiving Cytokine-Expressing Tumor Cells Are Associated With the Enhanced Survival of Mice Bearing Syngeneic Tumors

Shin-ichiro Fujii, Hirofumi Hamada, Koji Fujimoto, Taizo Shimomura, Makoto Kawakita
Journal: Blood
Blood (1999) 93 (12): 4328–4335.
https://doi.org/10.1182/blood.V93.12.4328
Published: 1999